➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Mallinckrodt
AstraZeneca
McKesson
Express Scripts

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Anamorelin


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Anamorelin?

Anamorelin is an investigational drug.

There have been 11 clinical trials for Anamorelin. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2011.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, and Cachexia. The leading clinical trial sponsors are Helsinn Therapeutics (U.S.), Inc, Helsinn Healthcare SA, and M.D. Anderson Cancer Center.

There are sixty-four US patents protecting this investigational drug and six hundred and fifty-three international patents.

Recent Clinical Trials for Anamorelin
TitleSponsorPhase
Anamorelin Study for Advanced Pancreatic CancerHelsinn Healthcare SAPhase 2
Anamorelin Study for Advanced Pancreatic CancerQuartesian LLCPhase 2
Anamorelin Study for Advanced Pancreatic CancerLahey ClinicPhase 2

See all Anamorelin clinical trials

Clinical Trial Summary for Anamorelin

Top disease conditions for Anamorelin
Top clinical trial sponsors for Anamorelin

See all Anamorelin clinical trials

US Patents for Anamorelin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Anamorelin   Try Before You Buy Antidiabetic compounds Merck Sharp & Dohme Corp. (Rahway, NJ)   Try Before You Buy
Anamorelin   Try Before You Buy Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Try Before You Buy
Anamorelin   Try Before You Buy Binding proteins and methods of use thereof NGM Biopharmaceuticals, Inc. (South San Francisco, CA)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Anamorelin

Drugname Country Document Number Estimated Expiration Related US Patent
Anamorelin European Patent Office EP3102198 2034-02-06   Try Before You Buy
Anamorelin World Intellectual Property Organization (WIPO) WO2015119899 2034-02-06   Try Before You Buy
Anamorelin Australia AU2017261372 2036-05-05   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Harvard Business School
AstraZeneca
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.